| arznei-telegramm

This is a translation of the table of contents. One article of each issue is translated and freely available.

table of contents

NEW ON THE MARKET

Lecanemab (LEQEMBI) in early Alzheimer’s disease

THERAPY FROM A CRITICAL VIEWPOINT

Cardiovascular data on tirzepatide (MOUNJARO) in type 2 diabetes

Withdrawal of andexanet alfa (ONDEXXYA) from the US market ... market withdrawal in the EU overdue

IN BRIEF

RSV: nirsevimab (BEYFORTUS) for infants versus vaccination of pregnant women

Laser therapy for nail fungus?
free

SIDE EFFECTS

Intestinal angioedema with ACE inhibitors and angiotensin II receptor blockers

Serious respiratory damage after aspiration of alendronate

UK: additional warnings for benzodiazepines, gabapentin, pregabalin, and Z-drugs

Independent drug information – in English

Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

Browse free articles